Malaria drug shortages in Kenya: a major failure to provide access to effective treatment.

Beth B Kangwana; Julius Njogu; Beatrice Wasunna; Sarah V Kedenge; Dorothy N Memusi; Catherine A Goodman ORCID logo; Dejan Zurovac; Robert W Snow; (2009) Malaria drug shortages in Kenya: a major failure to provide access to effective treatment. The American journal of tropical medicine and hygiene, 80 (5). pp. 737-738. ISSN 0002-9637 DOI: 10.4269/ajtmh.2009.80.737
Copy

A key bench mark of successful therapeutic policy implementation, and thus effectiveness, is that the recommended drugs are available at the point of care. Two years after artemether-lumefathrine (AL) was introduced for the management of uncomplicated malaria in Kenya, we carried out a cross-sectional survey to investigate AL availability in government facilities in seven malaria-endemic districts. One of four of the surveyed facilities had none of the four AL weight-specific treatment packs in stock; three of four facilities were out of stock of at least one weight-specific AL pack, leading health workers to prescribe a range of inappropriate alternatives. The shortage was in large part caused by a delayed procurement process. National ministries of health and the international community must address the current shortcomings facing antimalarial drug supply to the public sector.


picture_as_pdf
Malaria Drug Shortages in Kenya_GOLD VoR.pdf
subject
Published Version
Available under Creative Commons: 3.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads